Covid-19 alert: 1 in 7 volunteers for Russia’s Sputnik vaccine facing side-effects

Moscow: Russian health minister Mikhail Murashko said that one in seven volunteers have complained of side effects, including weakness and muscle pain after receiving the Sputnik V coronavirus vaccine, reported The Moscow Times. Results of the phase 1/2 trials of the vaccine published in The Lancet show no serious adverse effects and a stable immune response in 100 per cent of participants. Final clinical trials of the Sputnik V COVID-19 vaccine are currently ongoing.

Also read: Pulwama type attack averted in J&K, 52 kg of explosives recovered

Meanwhile, the Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Dr Reddy’s Laboratories Ltd, a global pharmaceutical company headquartered out of India, have agreed to cooperate on clinical trials and distribution of 100 million of doses of the Sputnik V vaccine in India.

Also read: Sushant Singh Rajput’s wax statue unveiled in West Bengal

“Approximately 14 per cent have small complaints of weakness, muscle pain for 24 hours and an occasional increase in body temperature,” Murashko was quoted as as saying by the state-run TASS news agency.

Murashko said the symptoms ‘level off’ by the next day, adding the complications are described in the instructions and are predictable.

Also read: First time Rajya Sabha member Ashok Gasti dies of Covid-19

The TASS, citing Murashko, reported more than 300 out of the announced 40,000 study volunteers have been inoculated so far. Volunteers are expected to receive a second shot of the vaccine within 21 days of the first dose, added the report.

According to Murashko, the general population could be given Sputnik V in late November or early December, even as developers began distributing small batches of the vaccine across Russian regions in parallel with the Phase 3 trials.

Show More

Related Articles

Back to top button
Live Updates COVID-19 CASES